Efficacy and safety of different doses and retreatment of rituximab: a randomised, placebo-controlled trial in patients who are biological naive with active rheumatoid arthritis and an inadequate response to methotrexate (Study Evaluating Rituximab's Efficacy in MTX iNadequate rEsponders (SERENE)).

Emery, P

Efficacy and safety of different doses and retreatment of rituximab: a randomised, placebo-controlled trial in patients who are biological naive with active rheumatoid arthritis and an inadequate response to methotrexate (Study Evaluating Rituximab's Efficacy in MTX iNadequate rEsponders (SERENE)). [electronic resource] - Annals of the rheumatic diseases Sep 2010 - 1629-35 p. digital

Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

1468-2060

10.1136/ard.2009.119933 doi


Adult
Aged
Antibodies, Monoclonal--administration & dosage
Antibodies, Monoclonal, Murine-Derived
Antirheumatic Agents--administration & dosage
Arthritis, Rheumatoid--drug therapy
Dose-Response Relationship, Drug
Double-Blind Method
Drug Therapy, Combination
Female
Humans
Male
Methotrexate--adverse effects
Middle Aged
Rituximab
Severity of Illness Index
Treatment Outcome